U.S. markets closed

Organigram Holdings Inc. (OGI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.3300-0.0100 (-0.75%)
At close: 04:00PM EST
1.2800 -0.05 (-3.76%)
After hours: 07:52PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Slow Stochastic

Slow Stochastic

Previous Close1.3400
Bid1.3200 x 900
Ask1.3700 x 1400
Day's Range1.3150 - 1.3750
52 Week Range0.9700 - 4.1200
Avg. Volume1,215,320
Market Cap107.945M
Beta (5Y Monthly)1.48
PE Ratio (TTM)N/A
EPS (TTM)-1.8500
Earnings DateDec 11, 2023 - Dec 22, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for OGI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Organigram Holdings Inc.
    Analyst Report: Canopy Growth CorporationCanopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
    Fair Value
    Economic Moat
    9 days agoMorningstar
View more
  • InvestorPlace

    If You Can Only Buy One Cannabis Stock in December, It Better Be One of These 3 Names

    Rapper Snoop Dogg announced on Nov. 17 that he was giving up smoking cannabis. Cannabis stocks fell on the news. “After much consideration & conversation with my family, I’ve decided to give up smoke. Please respect my privacy at this time,” Newsweek reported Snoop Dogg’s comments from X and Instagram. As anyone who’s followed cannabis stocks over the past few years knows, while the entertainer is a big participant in the industry both as an entrepreneur and user, cannabis problems are far bigge

  • InvestorPlace

    3 Underperforming Cannabis Stocks You Better Not Be Buying

    In an August 2023 column, I wrote “With the chances of marijuana companies accessing the U.S. financial system higher than ever and cannabis stocks trading at lower valuations than ever before, now looks like an excellent time to seek out top-notch cannabis stocks to buy.” I also identified three cannabis companies with very attractive valuations and strong outlooks. However, despite the fact that cannabis stocks in general had tumbled over 90% from their February 2021 peak as of October 2023, t

  • Business Wire

    Organigram Increases Investment in Phylos After Successful Milestone Achievement

    TORONTO, November 28, 2023--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that Phylos Bioscience Inc. ("Phylos"), a U.S. cannabis genetics company and provider of production ready seeds, has achieved the first milestone under the loan agreement entered into in May 2023 (the "Loan Agreement") and has closed the second tranche under the Loan Agreement with Organigram advancing US$2.75 million to Phylos.